2387510-88-3

2387510-88-3 structure
2387510-88-3 structure
  • Name: OD36 hydrochloride
  • Chemical Name: OD36 hydrochloride
  • CAS Number: 2387510-88-3
  • Molecular Formula: C16H16Cl2N4O2
  • Molecular Weight: 367.23
  • Catalog: Signaling Pathways Apoptosis RIP kinase
  • Create Date: 2022-10-11 20:25:04
  • Modify Date: 2024-01-12 19:01:32
  • OD36hydrochloride is a RIPK2 inhibitor with an IC50 of 5.3 nM. OD36 hydrochloride is a macrocyclic inhibitor with potent binding to the ALK2 kinase ATP pocket. OD36 hydrochloride shows ALK2-directed activity with KDs of 37 nM[1][2].

Name OD36 hydrochloride
Description OD36hydrochloride is a RIPK2 inhibitor with an IC50 of 5.3 nM. OD36 hydrochloride is a macrocyclic inhibitor with potent binding to the ALK2 kinase ATP pocket. OD36 hydrochloride shows ALK2-directed activity with KDs of 37 nM[1][2].
Related Catalog
Target

RIPK2:5.3 nM (IC50)

ACVR1:37 nM (Kd)

ACVR1:47 nM (IC50)

ALK2 R206H:22 nM (IC50)

In Vitro OD36 also inhibits ALK2 and ALK2 R206H with IC50s of 47 and 22 nM, respevtively[1]. OD36 shows activity against ALK1 with a KD of 90 nM[2]. OD36 potently antagonize mutant ALK2 signaling and osteogenic differentiation[2]. OD36 (0.1-1 μM; 24 h) efficiently inhibits BMP-6 (50 ng/mL)-induced p-Smad1/5 in KS483 cells[2]. Preincubation of fibrodysplasia ossificans progressiva (FOP) endothelial colony-forming cells (ECFCs) with OD36 (0.5 μM) completely prevents the activation of Smad1/5 and gene targets ID-1 and ID-3 in response to activin A[2]. Western Blot Analysis[2] Cell Line: KS483 cells Concentration: 0.1, 0.2, and 1 μM Incubation Time: 24 h Result: Inhibited BMP-6 induced p-Smad1/5.
In Vivo OD36 (6.25 mg/kg; i.p.; once) alleviates inflammation in an acute peritonitis mice model[3]. Animal Model: C57BL/6 mice, muramyl dipeptide (MDP)-induced model of peritonitis[3] Dosage: 6.25 mg/kg Administration: Intraperitoneal injection, 30 min prior to MDP Result: Inhibited the recruitment of inflammatory cells to the peritoneum, specifically that of neutrophils, and, to a lesser extent, lymphocytes. Decreased RIPK2-specific genes as well as inflammatory cytokine and chemokine gene expression.
References

[1]. Justine T Tigno-Aranjuez, et al. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease. J Biol Chem. 2014 Oct 24;289(43):29651-64.

[2]. Gonzalo Sánchez-Duffhues, et al. Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells. JBMR Plus. 2019 Oct 7;3(11):e10230.

[3]. Tigno-Aranjuez JT, et al. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease. J Biol Chem. 2014 Oct 24;289(43):29651-64.

Molecular Formula C16H16Cl2N4O2
Molecular Weight 367.23
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.